Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q2 2021 · 10-Q
Revenue$11.23K$11.23K−76.2% vs Q2 2020 Net Income-$101.99K-$101.99KN/M vs Q2 2020 EPS Diluted$0.00$0.00— vs Q2 2020 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Margins · derivedGross margin-156.9%−56.5 pt vs Q2 2020
Operating margin832.6%+1137.0 pt vs Q2 2020
Net margin-908.5%−604.1 pt vs Q2 2020
ended Nov 30, 2020 · filed Jan 19, 2021 · 50 d after period end